Svmuu News Former Pennsylvania Congressman Mike Hanna stated: "Since the moment the conflict began, Trump's timeline for how long it would last has been constantly shifting. Initially, he claimed it was a matter of days, then it became weeks, no more than three weeks, followed by five weeks. And of course, in recent days, the only word we've heard is 'soon.' So, these timelines keep changing, and there's a lack of transparency regarding the exact status of this conflict.
Given the erratic nature of the timeline, one can't help but question whether there was ever any real timeline from the start of the conflict, and whether the endgame was truly thought through before going to war. These are questions many Americans are asking. Why start such a war without knowing how to end it and without a predetermined exit path? Trump continues to try to construct an exit path, insisting that negotiations will take place and that he knows these negotiations will succeed. Despite all current signs once again pointing to the exact opposite being true." (Jin10)
Former U.S. Congressman: No One Knows How Fast Trump's "U.S.-Iran Conflict Will End Soon" Really Is
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
6
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
9
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
10
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
Markets Today
Recommended Reading






